Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study-Reference-Cited by-同舟云学术

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study

Published:2016-01-06 Issue: Volume:6 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Toth Peter P.,Patti Angelo M.,Nikolic Dragana,Giglio Rosaria V.,Castellino Giuseppa,Biancucci Teresa,Geraci Fabiana,David Sabrina,Montalto Giuseppe,Rizvi Ali,Rizzo Manfredi

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference52 articles.

1. New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia.;Adhyaru;Cardiol. Clin.,2015

2. Cardiovascular disease risk assessment and prevention: current guidelines and limitations.;Alagona;Med. Clin. North Am.,2015

3. 2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARgamma partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.;Andersen;Bioorg. Med. Chem.,2014

4. Low-density lipoprotein subclass patterns and risk of myocardial infarction.;Austin;JAMA,1988

5. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.;Banach;Expert Opin. Drug Saf.,2015a

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of naringin in the treatment of atherosclerosis;Frontiers in Pharmacology;2024-09-06

2. Exploring the Role of Bergamot Polyphenols in Alleviating Morphine-Induced Hyperalgesia and Tolerance through Modulation of Mitochondrial SIRT3;Nutrients;2024-08-09

3. Naringin: Cardioprotective properties and safety profile in diabetes treatment;Fitoterapia;2024-07

4. Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study;Food & Function;2024

5. Research Progress of Small Dense Low-Density Lipoprotein and Cardiovascular Disease;Advances in Clinical Medicine;2024